Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#111 / 200 Total
VINO - Gaucho Group Holdings Inc - Stock Price Chart
TickerVINO [NASD]
CompanyGaucho Group Holdings Inc
CountryUSA
IndustryReal Estate - Diversified
Market Cap3.90MEPS (ttm)-5.71
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y12.64%
P/S1.82EPS next 5Y-
P/B4.12EPS Q/Q50.42%
Dividend-Sales Q/Q42.07%
Insider Own14.58%Inst Own8.49%
Insider Trans0.00%Inst Trans-
Short Float1.22%Earnings-
Analyst Recom1.00Target Price13752.00
Avg Volume92.86K52W Range3.89 - 84.00
May-20-24 09:53PM VINO Stock Earnings: Gaucho Group Holdings Reported Results for Q1 2024 (InvestorPlace) +11.16%
May-15-24 10:45AM Gaucho Holdings Achieves Key Nasdaq Milestone (ACCESSWIRE) -6.62%
May-14-24 11:45AM Gaucho Holdings Announces Record Growth in Argentine Wine Market (ACCESSWIRE)
May-07-24 11:15AM Gaucho Group Holdings, Inc. Supports Strong Investment in Argentina Following Endorsements from Global Leaders (ACCESSWIRE) +18.35%
May-06-24 09:15AM Gaucho Group Holdings, Inc. Observes Notable Surge In Buenos Aires Real Estate Market (ACCESSWIRE) -5.67%
May-01-24 09:15AM Gaucho Group Holdings Announces Completion of Reverse Stock Split (ACCESSWIRE) -20.02%
Apr-29-24 09:00AM Gaucho Group Holdings, Inc. Announces Reverse Stock Split (ACCESSWIRE)
Apr-24-24 08:30AM Gaucho Group Holdings Receives Notice from Nasdaq Regarding Continued Listing Requirements (ACCESSWIRE)
Apr-19-24 10:00AM Gaucho Group Holdings Responds to Positive Economic Shifts in Argentina (ACCESSWIRE)
Apr-16-24 08:00PM Gaucho Group Holdings Announces Delay in Annual Report Filing (ACCESSWIRE)
HOVR - New Horizon Aircraft Ltd - Stock Price Chart
TickerHOVR [NASD]
CompanyNew Horizon Aircraft Ltd
CountryCanada
IndustryAerospace & Defense
Market Cap27.15MEPS (ttm)0.56
P/E2.64EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-609.09%
Dividend-Sales Q/Q-
Insider Own55.45%Inst Own12.58%
Insider Trans0.00%Inst Trans-
Short Float0.18%Earnings-
Analyst Recom-Target Price-
Avg Volume130.02K52W Range1.00 - 12.14
May-08-24 08:00AM Horizon Aircraft Provides Update on Technical Flight Testing Progress (GlobeNewswire)
May-06-24 04:15PM Horizon Aircraft Announces Participation in the EF Hutton Annual Global Conference (Newsfile)
Apr-22-24 05:02AM The aviation industry is looking for its own Tesla (Yahoo Finance)
Apr-16-24 08:30AM Horizon Aircraft Provides Corporate Update (GlobeNewswire)
Mar-19-24 08:00AM Japanese Investors Believe Increased Global Urbanisation is Set to Fuel Growth in eVTOL Sector (GlobeNewswire)
Mar-04-24 04:15PM Horizon Aircraft to Participate in the 36th Annual Roth Conference on March 18 and 19, 2024 (GlobeNewswire)
Feb-27-24 08:00AM Major Investors Expect First Commercial eVTOL Passenger Routes to be Operational by 2026 (GlobeNewswire)
Jan-24-24 04:15PM Horizon Aircraft to Ring the Nasdaq Closing Bell on Thursday, January 25, 2024 to Commemorate Public Listing (GlobeNewswire) -5.51%
Jan-16-24 08:00AM Horizon Aircraft Enters into Letter of Intent to Purchase $250M of Cavorite X7 Aircraft, with an Option for up to $500M (GlobeNewswire) -41.26%
Jan-12-24 12:47PM Horizon Aircraft Completes Business Combination with Pono Capital Three, Inc. to Become a Publicly Traded Company (GlobeNewswire)
SXTC - China SXT Pharmaceuticals Inc - Stock Price Chart
TickerSXTC [NASD]
CompanyChina SXT Pharmaceuticals Inc
CountryChina
IndustryDrug Manufacturers - Specialty & Generic
Market Cap0.69MEPS (ttm)-1.16
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.41EPS next 5Y-
P/B4.34EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own3.13%Inst Own0.51%
Insider Trans0.00%Inst Trans297.32%
Short Float2.61%Earnings-
Analyst Recom-Target Price-
Avg Volume971.76K52W Range0.94 - 9.38
Oct-26-23 04:05PM China SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaq's Minimum Bid Price Rule (GlobeNewswire)
Oct-04-23 08:30AM China SXT Pharmaceuticals Announces One-for-Twenty-five Reverse Stock Split (GlobeNewswire)
Aug-02-23 06:03AM China SXT Pharmaceuticals Full Year 2023 Earnings: US$0.89 loss per share (vs US$5.52 loss in FY 2022) (Simply Wall St.)
May-10-23 08:00AM China SXT Pharmaceuticals, Inc. Receives 180-day Extension from Nasdaq to Meet Minimum Bid Price Rule (GlobeNewswire) +6.05%
Mar-29-23 09:43AM Insiders who placed huge bets on China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) earlier this year would be disappointed with the 12% drop (Simply Wall St.)
Nov-07-22 08:00AM China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency (GlobeNewswire)
May-18-22 12:30PM China SXT Pharmaceuticals, Inc. Announces 1 for 20 Reverse Share Split (GlobeNewswire) -27.93%
Mar-14-22 10:33PM China SXT Pharmaceuticals, Inc. Enters into Securities Purchase Agreement to Issue a 6% Convertible Promissory Note in the Original Principal Amount of $2.8 Million (GlobeNewswire) -9.81%
Jan-20-22 12:30PM Aegis Capital Corp. Acted as Sole Bookrunner on a $4.1 Million Underwritten Public Offering of Ordinary Shares, Inclusive of the Over-Allotment, for China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC). (ACCESSWIRE)
10:45AM China SXT Pharmaceuticals, Inc. Announces Successful Closing of $4.1 Million Follow-on Underwritten Offering of Ordinary Shares and Pre-Funded Warrants With Simultaneous Exercise of the Over-Allotment (GlobeNewswire)
AWIN - AERWINS Technologies Inc - Stock Price Chart
TickerAWIN [NASD]
CompanyAERWINS Technologies Inc
CountryUSA
IndustryScientific & Technical Instruments
Market Cap4.61MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-99.99%
Dividend-Sales Q/Q-
Insider Own32.61%Inst Own1.11%
Insider Trans0.00%Inst Trans-20.28%
Short Float18.70%Earnings-
Analyst Recom1.00Target Price100.00
Avg Volume1.01M52W Range2.12 - 74.40
May-16-24 07:34AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday (InvestorPlace) -18.47%
May-15-24 02:31PM Is Aerwins Technologies (AWIN) Stock the Next Big Short Squeeze? (InvestorPlace) +131.73%
Apr-23-24 05:15PM AERWINS Technologies Announces Additional Staff Determination (GlobeNewswire) -5.13%
Mar-28-24 11:25AM AERWINS Technologies Announces 1-For-100 Reverse Stock Split (GlobeNewswire) -12.90%
Dec-04-23 07:21AM 10 Best Debt Free Penny Stocks To Buy Now (Insider Monkey)
Oct-24-23 08:41AM Why Is Aerwins Technologies (AWIN) Stock Up 26% Today? (InvestorPlace) +8.51%
07:45AM Todays Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace)
Oct-09-23 08:30AM AERWINS Plans to Obtain XTURISMO FAA Approval Established US Subsidiary (Newsfile) +13.23%
Oct-03-23 08:03AM Why Is Aerwins Technologies (AWIN) Stock Down 18% Today? (InvestorPlace) -16.77%
Oct-02-23 07:44AM Why Is Aerwins Technologies (AWIN) Stock Up 112% Today? (InvestorPlace) +89.57%
TFFP - Tff Pharmaceuticals Inc - Stock Price Chart
TickerTFFP [NASD]
CompanyTff Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap7.10MEPS (ttm)-10.21
P/E-EPS this Y60.34%
Forward P/E-EPS next Y17.23%
PEG-EPS past 5Y-13.86%
P/S-EPS next 5Y-
P/B1.09EPS Q/Q50.69%
Dividend-Sales Q/Q-
Insider Own7.13%Inst Own11.45%
Insider Trans0.00%Inst Trans9.25%
Short Float4.30%EarningsMay 14/a
Analyst Recom1.00Target Price17.00
Avg Volume41.24K52W Range1.54 - 16.94
May-20-24 11:37AM TFF Pharmaceuticals Advances Influenza Vaccine Candidates Into Preclinical Testing (MT Newswires) +6.02%
07:00AM TFF Pharmaceuticals and Cleveland Clinic to Advance Multivalent Universal Influenza Vaccine Candidates into Preclinical Testing (GlobeNewswire)
May-15-24 07:00AM TFF Pharmaceuticals Provides Update on Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial for the Prevention of Lung Transplant Rejection (GlobeNewswire) +8.06%
May-14-24 10:54PM TFFP Stock Earnings: TFF Pharmaceuticals Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace)
06:00PM TFF Pharmaceuticals, Inc. (TFFP) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM TFF Pharmaceuticals Reports First Quarter Financial Results and Provides Corporate Update (GlobeNewswire)
May-01-24 05:07PM TFF Pharmaceuticals Announces Closing of Pricing of $4.8 Million Public Offering (GlobeNewswire)
Apr-30-24 05:53AM TFF Pharmaceuticals Prices $4.8 Million Public Offering; Shares Down Pre-Bell (MT Newswires)
Apr-29-24 08:00PM TFF Pharmaceuticals Announces Pricing of $4.8 Million Public Offering (GlobeNewswire) -7.24%
10:00AM TFF Pharmaceuticals Makes Available Phase 2 Data from Tacrolimus Inhalation Powder (TFF TAC) for the Prevention of Lung Transplant Rejection Presented at the Recent ISHLT Annual Meeting (GlobeNewswire)
PTIX - Protagenic Therapeutics Inc - Stock Price Chart
TickerPTIX [NASD]
CompanyProtagenic Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap6.39MEPS (ttm)-1.37
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-2.91%
P/S-EPS next 5Y-
P/B2.99EPS Q/Q-133.79%
Dividend-Sales Q/Q-
Insider Own19.99%Inst Own8.08%
Insider Trans0.00%Inst Trans-1.54%
Short Float0.26%EarningsApr 01/a
Analyst Recom1.00Target Price16.00
Avg Volume11.29K52W Range0.68 - 2.32
May-01-24 08:38AM Protagenic Therapeutics Completes Enrollment in Single Dose Portion of Phase 1 of Innovative Stress Disorder Trial (ACCESSWIRE) -5.58%
Apr-17-24 08:42AM Protagenic Therapeutics' Innovative Peptide PT00114 to be Highlighted at Boston Summit (ACCESSWIRE)
Apr-01-24 09:53PM PTIX Stock Earnings: Protagenic Therapeutics Reported Results for Q4 2023 (InvestorPlace)
04:20PM Protagenic Therapeutics Reports Fourth Quarter and Full Year 2023 Results (ACCESSWIRE)
Mar-27-24 08:42AM Protagenic Therapeutics Successfully Concludes Third Cohort in Single Dose Portion of Phase 1 Trial for Stress-Related Neuropsychiatric Disorders (ACCESSWIRE)
Mar-25-24 05:00PM Protagenic Therapeutics Schedules First Q4 and FY 2023 Earnings Call (ACCESSWIRE) +12.37%
Mar-21-24 08:41AM Protagenic Therapeutics Announces Resolution of Nasdaq Deficiency Notice (ACCESSWIRE) +5.93%
Feb-13-24 08:30AM Protagenic Therapeutics Achieves First Clinical Safety Milestone with its Novel Neuropeptide for the Potential Treatment of Stress-Related Disorders (ACCESSWIRE)
Dec-12-23 07:30AM Protagonist Reports 2-Year Follow Up Data from Rusfertide REVIVE Study at the ASH Annual Meeting Showing Durable Efficacy and No New Safety Signals (ACCESSWIRE) +15.65%
Oct-13-23 09:00AM Protagenic Therapeutics Announces Date of Annual Shareholder Meeting (ACCESSWIRE) +13.49%
POET - POET Technologies Inc - Stock Price Chart
TickerPOET [NASD]
CompanyPOET Technologies Inc
CountryCanada
IndustrySemiconductors
Market Cap94.33MEPS (ttm)-0.49
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y2.67%
P/S325.27EPS next 5Y20.00%
P/B19.97EPS Q/Q10.23%
Dividend-Sales Q/Q-95.18%
Insider Own1.35%Inst Own15.47%
Insider Trans0.00%Inst Trans-13.57%
Short Float2.73%EarningsMay 15/a
Analyst Recom1.00Target Price3.00
Avg Volume714.68K52W Range0.72 - 5.88
May-16-24 07:53AM POET Stock Earnings: POET Technologies Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace) -8.47%
May-15-24 05:30PM POET Technologies Reports First Quarter 2024 Financial Results (GlobeNewswire)
May-14-24 11:34AM Update: POET Technologies Jumps 9.4% as it Collaborates with Foxconn Interconnect Technology for High-Speed AI Systems (MT Newswires) +10.09%
08:28AM POET Technologies to Collaborate with Foxconn Interconnect Technology for High-Speed AI Systems (MT Newswires)
07:44AM POET Technologies Working With Foxconn Interconnect Technology on High-Speed AI Systems; Shares Rise Pre-Bell (MT Newswires)
07:00AM POET Announces Design Win and Collaboration with Foxconn Interconnect Technology for High-speed AI Systems (GlobeNewswire)
May-10-24 11:10AM Poet Technologies Completes $10-Million Private Placement of Share Units (MT Newswires)
10:28AM POET Announces Closing of Private Placement Financing for CAD$10 Million (GlobeNewswire)
May-03-24 01:33PM POET Technologies Down Near 12% As Co Raises $10 Million (MT Newswires) -13.50%
11:45AM POET Announces Closing of CAD$10 Million Non-brokered Financing with a Single Institutional Investor (GlobeNewswire)
CDXC - Chromadex Corp - Stock Price Chart
TickerCDXC [NASD]
CompanyChromadex Corp
CountryUSA
IndustryBiotechnology
Market Cap238.71MEPS (ttm)-0.05
P/E-EPS this Y78.57%
Forward P/E50.56EPS next Y516.67%
PEG-EPS past 5Y35.83%
P/S2.87EPS next 5Y-
P/B8.20EPS Q/Q74.41%
Dividend-Sales Q/Q-1.79%
Insider Own35.90%Inst Own17.55%
Insider Trans0.02%Inst Trans-19.21%
Short Float3.35%EarningsMay 08/a
Analyst Recom1.00Target Price6.67
Avg Volume353.50K52W Range1.25 - 4.65
May-10-24 03:22PM ChromaDex Corp (CDXC) Q1 2024 Earnings: Aligns with EPS Projections, Misses Revenue Estimates (GuruFocus.com)
May-09-24 02:34PM ChromaDex Corporation (NASDAQ:CDXC) Q1 2024 Earnings Call Transcript (Insider Monkey) -8.09%
07:17AM Q1 2024 Chromadex Corp Earnings Call (Thomson Reuters StreetEvents)
03:42AM ChromaDex Corp (CDXC) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges and ... (GuruFocus.com)
May-08-24 08:58PM CDXC Stock Earnings: ChromaDex Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace)
05:04PM ChromaDex: Q1 Earnings Snapshot (Associated Press Finance)
04:04PM ChromaDex Corporation Reports First Quarter 2024 Financial Results (Business Wire)
Apr-30-24 08:32AM ChromaDex's NIAGEN (Patented Nicotinamide Riboside, NR), the Most Efficient and High-Quality NAD+ Precursor, Featured in New Solgar Cellular Nutrition Cellular Energy Supplement (Business Wire)
Apr-25-24 08:34AM ChromaDex Announces Nationwide Launch of Tru Niagen at The Vitamin Shoppe (Business Wire)
Apr-24-24 08:34AM ChromaDex to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024 (Business Wire)
GNLX - Genelux Corp - Stock Price Chart
TickerGNLX [NASD, RUT]
CompanyGenelux Corp
CountryUSA
IndustryBiotechnology
Market Cap116.10MEPS (ttm)-0.97
P/E-EPS this Y20.91%
Forward P/E-EPS next Y-29.34%
PEG-EPS past 5Y-23.84%
P/S11610.00EPS next 5Y-
P/B7.70EPS Q/Q30.73%
Dividend-Sales Q/Q-95.29%
Insider Own25.33%Inst Own22.36%
Insider Trans-4.71%Inst Trans-
Short Float11.52%EarningsMay 09/a
Analyst Recom1.00Target Price26.00
Avg Volume127.75K52W Range3.06 - 40.98
May-09-24 11:53PM GNLX Stock Earnings: Genelux Misses EPS for Q1 2024 (InvestorPlace) +6.07%
04:25PM Genelux Corporation Reports First Quarter 2024 Financial Results and Provides General Business Updates (GlobeNewswire)
Apr-26-24 09:35AM Down -48.37% in 4 Weeks, Here's Why Genelux Corporation (GNLX) Looks Ripe for a Turnaround (Zacks)
Apr-23-24 09:35AM Down -45.44% in 4 Weeks, Here's Why Genelux Corporation (GNLX) Looks Ripe for a Turnaround (Zacks)
Apr-05-24 09:35AM After Plunging -26.21% in 4 Weeks, Here's Why the Trend Might Reverse for Genelux Corporation (GNLX) (Zacks)
Apr-04-24 12:00PM All You Need to Know About Genelux Corporation (GNLX) Rating Upgrade to Buy (Zacks)
Apr-02-24 07:52AM GNLX Stock Earnings: Genelux Misses EPS for Q4 2023 (InvestorPlace)
Apr-01-24 07:00AM Genelux Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update (GlobeNewswire) -18.51%
Dec-15-23 03:01PM Insider Sell Alert: Director James Tyree Offloads 9,000 Shares of Genelux Corp (GNLX) (GuruFocus.com) -13.23%
Nov-27-23 07:00AM Genelux Corporation Receives FDA Fast Track Designation for Olvi-Vec in Platinum Resistant/Refractory Ovarian Cancer (GlobeNewswire)
FOSL - Fossil Group Inc - Stock Price Chart
TickerFOSL [NASD, RUT]
CompanyFossil Group Inc
CountryUSA
IndustryLuxury Goods
Market Cap76.75MEPS (ttm)-2.67
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-111.68%
P/S0.06EPS next 5Y14.90%
P/B0.33EPS Q/Q41.85%
Dividend-Sales Q/Q-21.58%
Insider Own10.80%Inst Own55.15%
Insider Trans0.00%Inst Trans-7.99%
Short Float12.88%EarningsMay 08/a
Analyst Recom4.00Target Price3.75
Avg Volume798.52K52W Range0.75 - 2.92
May-15-24 06:04AM Why the 2024 meme stock action is much tamer than 2021 so far (Yahoo Finance) -7.38%
May-10-24 09:51AM Fossil Group, Inc. (NASDAQ:FOSL) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-09-24 06:56AM Q1 2024 Fossil Group Inc Earnings Call (Thomson Reuters StreetEvents)
03:53AM Fossil Group Inc (FOSL) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges with ... (GuruFocus.com)
May-08-24 10:55PM FOSL Stock Earnings: Fossil Group Reported Results for Q1 2024 (InvestorPlace)
06:30PM Fossil Group Sees First-Quarter Revenues Slide After a Dismal 2023 (WWD)
06:06PM Fossil Group: Q1 Earnings Snapshot (Associated Press Finance)
04:15PM Fossil Group, Inc. Reports First Quarter 2024 Financial Results (GlobeNewswire)
May-02-24 01:09PM Fossil Group (FOSL) Fell Due to Near-Term Revenue Headwinds (Insider Monkey) +12.68%
12:56PM Gray Television (GTN) Was Under Pressure in Q1 (Insider Monkey)
1⋯7891011121314151617⋯20
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.